INTRODUCTION:
For oral sustained or prolonged-release dosage forms, mu ltip le units are more advantageous than single units because they disperse widely and uniformly along the gastrointestinal tract and could lessen intra-and intersubject variability. Gastric-retentive systems, mult iple units, may have the advantage of avoiding all-or -nothing emptying, and increase the probability that some of the dosage form will remain in the stomach 1 . Approaches devising multiple unit floating systems include mult iple unit HBS, polycarbonate microspheres 2 , alginate beads 3 , charged ion exchange resins with bicarbonate 4, 5, 6 , air compart ment mu ltip le unit systems, coated granules with a dual effervescent layer 7 and emulsion solvent diffusion 8, 9, 10 .
There are various approaches in delivering substances to the target site in a controlled release fashion via oral route. One such approach is using polymeric hollow microsphere as carrier for drugs. Hollow microspheres are known as the microballoonsdue to their low-density core 11 . Microballoons based drug delivery systems have received considerable attention in recent years. The most important characteristics of microballoons are microphase separation morphology, which endows it with a controllable variability in degradation rate and also drug release. 12, 13 Multiple unit systems such as microballoons capable of floating on the gastric fluid have the advantage that they are not subjected to "all or nothing" gastric emptying nature of single unit systems. Drug loaded polymeric microballoons and ion-exchange beads capable of floating on the gastric flu ids have therefore been examined as FDF.
Norflo xacin is a potent antibacterial agent having very broad spectrum of its activity. It acts by inhibiting DNA Gy rase and hence it is specific bacterial DNA Gyrase blocker, thus it inhibits the synthesis of DNA in bacteria leading to its rapid lyses 14 . Owing to the variable transit time in gastro intestinal tract of all dosage forms, it could not be ascertained to localize a dosage form at the site of maximu m absorption of a drug. So it was proposed to prepare floating microballoons of norflo xacin to localize the drug at its site of maximu m absorption.
For the development of floating microballoons of norflo xacin, a co mbination of polymer Eudragit RS 100 and Eudragit L 100 was selected. These polymers are comes under the category of polymethacrylates. Anionic acrylic poly mer Eudrag it L 100 is insoluble in acid media i.e. resistant to gastric fluid, and dissolves only in the neutral to weakly alkaline mediu m of the small intes tine. Permeable acrylic po ly mer Eudrag it RS 100 is water insoluble over the entire pH range, but swells in digestive flu ids independently of pH. In the swollen state it is permeab le to water and dissolved actives 15 .
In this study, an emulsion solvent diffusion/evaporation technique was used to prepare a floating controlled-release system for norflo xacin and the influence of several factors on various physical characteristics, including the particle size, drug loading , dissolution and floating properties of the resulting microspheres, were investigated.
MATERIAL AND MET HOD:
MATERIAL: The gift samp le of No rflo xacin was obtained from Aurochem Pharma. Pvt. Ltd. Mumbai. Eudragit L-100 and Eudragit RS-100 were obtained as a gift sample fro m pharmachem, Gu jrat. Rest of the chemicals was of analytical grade.
ABS TRACT
The present study involves preparation and evaluation of floating microballoons of norfloxacin for improving the bioavailability by prolongation of gastric residence time. Norfloxacin, a sparingly water soluble drug, was selected and microballoons were prepared by emulsion solvent diffusion method using Eudragit L-100 and Eudragit RS-100 in ethyl alcohol and dichloromethane organic solvent system. The formation of a sphere and hollow within the sphere was confirmed through SEM studies. The percentage of drug entrapment and recovery was found to be 75-80%. The micromeritic properties indicated better flowability and packability of the spheres. The Buoyancy test showed good floatability of norfloxacin microballoons in the simulated gastric fluid for more than 12 h. In vitro dissolution profile showed prolonged release of drug from the formulations. Thus microballoons of norfloxacin with acrylic polymers prepared by emulsion solvent diffusion proves to be an ideal novel floating dosage form that is adaptable to any intragastric condition for controlled drug delivery and enhanced bioavailability.
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MET HOD:
Microballoons with an internal hollow structure were prepared by solvent diffusion-evaporation method 16 . Equal quantities of two polymers i.e. Eudragit L-100 and Eudragit RS-100 were dissolved in ethanol, followed by the addition of isopropanol and dichloromethane. Then drug was homogeneously dispersed in this poly mer solution. This polymer solution was slowly introduced into poly-vinyl alcohol (PVA) aqueous solution with stirring using a mechanical stirrer equipped with a propeller. The solution was stirred for 1 hour and microballoons were collected by filtrat ion and washed 3 times with distilled water, dried at 40 o C and kept in desiccators 17 .
CHARACTERIZATION OF NORFLOXACIN MICROB ALLOONS
18, 19, 20
Morphology:
The surface morphology of microballoons selected on the basis of optical microscopy was visualized by scanning electron microscopy. The samples for SEM were prepared by lightly sprinkling the microballoons powder on a double adhesive tape which s tuck to an aluminum stub. The stubs were then coated with gold to a thickness of about 300 o A using a sputter coater. These samples were than randomly scanned and photomicrographs were taken which are shown in Fig. 1 . 
Percent yiel d of microballoons
The prepared microballoons were collected and weighed. The weight of microballoons was divided by the total weight of all the non-volatile components used for the preparation of the microballoons.
% yield = weight of microballoons collected / wt. of all non-vol atile components used for the preparati on x 100 
Percentage drug loadi ng efficiency:
The prepared microballoons were digested in minimu m quantity of ethanol (95%), and then diluted with acetate buffer (pH 4.6) up to 10 ml. The digested homogenate was centrifuged at 3000 rp m for 3 minutes and the supernatant after suitable dilution was assayed for norflo xacin spectrophotometrically.
The percentage drug entrapment is calculated fro m the equation given below. 
In vitro fl oating behavi or:
The floating test of the microballoons was carried out using the Dissolution test Apparatus method II specified in the USP XX 21 . The unloaded microballoons (800 mg ) were spread over the surface of the simulated gastric flu id pH 1.2 (900 ml, 37 ± 0.5 o C) wh ich was agited by a paddle rotated at 100 rp m. Dissolution test solution SGF (pH 1.2) containing Tween 20 (0.02% w/v) was used as dispersion med iu m to simulate gastric fluid. After ag itation for a previously determined interval, the microballoons that were floating and the ones that settled to the bottom of the flask were recovered separately.
After drying, the fraction of the microballoons was weighed; the % buoyancy of the microballoons was calculated by the follo wing equation:
Percent buoyancy = Q f / (Q f + Qs) × 100
Where, Qs is the weight of the settled microballoons, Q f is weight of microballoons that were floating. The results are shown in Table 4 and graphically presented in Fig. 4 . Figure 4: % buoyancy of different unloaded formu lations in SGF at 37 ± 1 o C
In vi tro drug release:
The optimized nine formu lations of norflo xacin microspheres e.g. OESTDP 1 ……OESTDP 8 were selected for the in vit ro drug release studies. The drug release studies of microballoons were carried out in Dissolution Test Apparatus II USP XX by the paddle method. Microballoons equivalent to 800 mg of norflo xacin were gently spread over the surface of 900 ml of d issolution med iu m (SGF pH 1.2,) as specified in the Indian pharmacopoeia 2007.
The paddle was rotated at 100 rp m and the temperature of dissolution med iu m was thermostatically controlled at 37 ± 0.5 o C. The samples were withdrawn at a suitable intervals of time fro m the dissolution vessel and were assayed after appropriate dilution spectrophotometrically at 278 n m in acidic mediu m for norflo xacin using Shimad zu 1700 (UVVisib le spectrophotometer) 
RES ULTS AND DISCUSS ION:
The floating microballoons were prepared by emu lsion solvent diffusion evaporation method using combination of polymers (Eudrag it L 100 and Eudragit RS 100). Formation of a stable o/w emu lsion at the initial stage and the precipitation of the polymer at the surface of the dispersed droplet were the key factors in preparing desirable floating microballoons. The counter diffusion of ethanol and water through the interface between the emu lsion droplet and the aqueous mediu m reduced the solubility of the polymer at the interface with the droplet inducing precipitation of the polymer on the surface of the emu lsion droplet. The dispersed droplet of the emulsion was enclosed with a film like shell of the poly mer. Based on the results from the o/w solvent diffusion method, the solvent composition of dichloro methane: ethanol: isopropanol (5: 8: 2) was considered and used in preparations.
Formulat ions are optimized fo r different process variables like So lvent ratio (dichlo ro methane: ethanol: isopropanol), drug-polymer ratio, Emu lsifier concentration, temp. and stirring speed which are represented in the article as O,D,E,T and S respectively.
The scanning electron microphotograph clearly indicates that the microspheres are spherical in shape and there is a formation of hollow cavity in the sphere (Fig 1) . It was clear that the solubility of the drug will determine the preferential location of the drug among the solvents used. Norflo xacin being water insoluble has a high entrapment in the microballoons. One more factor that has a high entrapment of drug was the proportion of Eudragit RS 100 in the polymer phase. As the proportion of Eudragit RS 100 was increased, the entrapment efficiency decreased owing to high porous nature of the polymer.
It was found that most of the microballoons were still floatable even after 24 hours of testing because of their low density and owing to the internal voids being completely conserved during the test. This finding indicated that the enteric property of the microballoons shell might be advantageous in prolonging the residence time of microballoons in the stomach, since dissolution and disruption of the microballoons could be prevented.
A combination of polymer was used for the current study to design a perfect gastro retentive delivery system which released most of the drug in upper part of gastrointestinal tract. As the amount of Eudragit RS 100 used in the preparation was increased the release of the drug was also increased. It may be concluded from this in vitro drug release study that the release rate can be controlled by varying the polymer: poly mer rat io and the dosage form could be designed to give the release in a controlled fashion at the desired site. As for norflo xacin, the site of absorption is upper GI tract, the formu lation OESTDP 3 and OESTDP 5 can serve the needs of a controlled release in upper GIT.
The data obtained from in vitro dissolution studies were fitted into Zero order, First order and Kors meyer-Peppas models. Regression analysis suggests that the release of drug from microballoons followed non-Fickian diffusion mechanis m.
CONCLUS ION:
The microballoons of norflo xacin prepared by emulsionsolvent diffusion method exhib ited excellent in vitro buoyancy and the drug release was sufficiently sustained with non-Fickian transport of drug fro m the microballoons. Hence the floating hollow microspheres of norflo xacin prepared with acrylic poly mers may provide a convenient dosage form for ach ieving better floating behavior and drug release.
